Reuters logo
BRIEF-CymaBay reports Q3 loss per share $0.21
November 8, 2017 / 9:16 PM / 14 days ago

BRIEF-CymaBay reports Q3 loss per share $0.21

Nov 8 (Reuters) - CymaBay Therapeutics Inc:

* CymaBay reports third quarter 2017 financial results and corporate updates

* Q3 loss per share $0.21

* Q3 earnings per share view $-0.19 -- Thomson Reuters I/B/E/S

* CymaBay Therapeutics - ‍cash, cash equivalents and marketable securities totaled $102.2 million at end of Q3 of 2017, compared to $17.0 million at Dec 31, 2016​

* CymaBay Therapeutics Inc - ‍existing cash expected to fund operations into 2019​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below